AISAP Cardio vs VX1
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your clinical setting requires rapid, comprehensive cardiac diagnostic assessments at the point of care. This tool is ideal for emergency departments, critical care units, or primary care where early detection of structural heart disease and heart failure is crucial for timely patient management, leveraging AI for automated interpretations and reports.
View AISAP Cardio →Choose VX1 if…
Choose VX1 if you are an electrophysiologist performing atrial fibrillation or atrial tachycardia ablation procedures and require real-time, AI-guided assistance for identifying dispersed electrograms. This software is specifically designed to integrate with existing EP lab systems to enhance procedural precision, reduce variability, and potentially improve ablation outcomes.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | VX1 |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based | Software integrated with existing electrophysiology (EP) lab mapping and recording systems. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed for rapid, point-of-care use by a broad range of clinicians, including non-cardiologists, enabling them to interpret complex cardiac ultrasounds with minimal training and real-time feedback. This broadens access to advanced diagnostics at the bedside, making it more widely usable across various clinical settings.
Clinical Value
AISAP CardioAISAP Cardio has demonstrated high sensitivity and specificity in detecting various cardiac pathologies, enabling non-cardiologists to perform expert-level interpretations at the point of care and leading to care pathway changes in a third of scanned patients. Its ability to provide early, accurate diagnoses for a broad range of structural heart diseases and heart failure impacts a larger patient population.
Pricing & Value
TieBoth tools explicitly state that pricing information is not publicly available and requires direct contact for a demo and pricing. Without any transparent pricing details, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.
Enterprise Readiness
AISAP CardioAISAP Cardio is a cloud-based SaaS platform that is explicitly stated to be HIPAA-compliant and ISO-certified, offering seamless integration with existing EHR/EMR and PACS systems. Its vendor-agnostic and scalable nature, coupled with its deployment in leading U.S. health systems, demonstrates a robust enterprise readiness.
Innovation
AISAP CardioAISAP Cardio is pioneering by being the first to receive FDA clearance for comprehensive POCUS diagnosis of structural heart diseases, enabling non-cardiologists to accurately interpret complex cardiac conditions at the bedside, even from a single ultrasound view. This significantly broadens access to early and accurate cardiac diagnostics.
Support & Docs
VX1Volta Medical's VX1 explicitly references and provides access to a 'VX1 SYSTEM USER MANUAL' on its product page, indicating readily available and structured documentation for users. No specific details regarding support or documentation were found for AISAP Cardio.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | VX1 |
|---|---|---|
| Tool Name | AISAP Cardio | VX1 |
| Company | Aisap | Volta Medical |
| Primary Use Case | AI-powered point-of-care ultrasound (POCUS) software for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Primary Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology |
| Key AI Functionality | AI-powered interpretation for early cardiac disease detection; automated generation of analyses, interpretations, and reports. | AI-guided real-time identification of dispersed electrograms (EGMs); analyzes 3D anatomical and electrical maps of human atria; designed to reduce inter-operator variability and standardize outcomes. |
| Specific Measurements/Assisted Procedures | Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis); Measurement of Left Ventricle Ejection Fraction (LVEF); Measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. | Assists cardiologists during AFib and atrial tachycardia ablation procedures; provides cycle length estimation from electrograms. |
| Integration Capabilities | Integration with existing clinical workflows, EHR/EMR, and PACS; vendor-agnostic and scalable solution. | Compatible with most EP recording, 3D navigation systems, and mapping catheters; integrated with existing electrophysiology (EP) lab mapping and recording systems. |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and VX1.